Position in NTRA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$23,798,810
+$19,217,010 QoQ
Shares Held
119,000
+495.0% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.96%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Soleus Capital Management, L.P. holds $120,978,490 across 6 Diagnostics & Research names. NTRA ranks #2 (19.7% of the industry book) .
All Filings in NTRA
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,798,810 | 119,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,581,800 | 20,000 | Shares | Sole | 2026-02-12 | |
| 2024-09-30 | $3,795,805 | 29,900 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $389,844 | 3,600 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,957,020 | 87,000 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $2,715,932 | 61,377 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,213,808 | 168,800 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $16,333,984 | 294,200 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $12,079,990 | 275,673 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,673,579 | 131,873 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,305,400 | 155,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $21,255,470 | 227,599 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $15,488,934 | 138,989 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $11,561,781 | 101,839 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,944,388 | 78,239 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,383,289 | 74,189 | Shares | Sole | 2021-04-29 | |
| 2020-09-30 | $7,302,669 | 101,089 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||